L3VLUP
ProSign in

PHG in the 13F filings

Koninklijke Philips NV · CUSIP 500472303

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q1 2025Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Quarter end
30 Sep 2022
the date the book describes
Filed
14 Nov 2022
latest of these filings; the earliest 14 Nov 2022
Managers listing it
5
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q2 2022 and Q3 2022; 5 listed it in both
Shares listed
32,244,518
combined, among listed positions
Reported value
$502m
combined, at the quarter end

Managers listing PHG in Q3 2022

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2022, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

5 of 5 holders

ActionFiling
Harris Associates LP20,233,663$317m0.53%Added+3,243,65114 Nov 2022 (the filing on sec.gov)
Wellington Management Group LLP7,845,101$121munder 0.1%Added+106,22814 Nov 2022 (the filing on sec.gov)
D. E. Shaw & Co.2,679,973$41munder 0.1%Trimmed-201,78514 Nov 2022 (the filing on sec.gov)
Voloridge Investment Management LLC752,101$12m0.06%Trimmed-94,10314 Nov 2022 (the filing on sec.gov)
Two Sigma Investments LP733,680$11munder 0.1%Trimmed-143,25814 Nov 2022 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2022 to Q3 2022, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
10 in Q1 2022 to 1 in Q2 2026

Tracked managers listing it, at least.

03581020142015201620172018201920202021202220252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
PHG by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20134$1.0bnn.a.n.a.
Q3 20135$1.1bnn.a.n.a.
Q4 20134$1.2bnn.a.n.a.
Q1 20144$1.1bnn.a.n.a.
Q2 20143$1.0bnn.a.n.a.
Q3 20144$1.1bnn.a.n.a.
Q4 20146$995mn.a.n.a.
Q1 20154$916mn.a.n.a.
Q2 20159$579mn.a.n.a.
Q3 20157$320mn.a.n.a.
Q4 20155$323mn.a.n.a.
Q1 20164$340mn.a.n.a.
Q2 20166$278mn.a.n.a.
Q3 20165$80mn.a.n.a.
Q4 20162$2.0mn.a.n.a.
Q1 20177$236mn.a.n.a.
Q2 20177$329mn.a.n.a.
Q3 20178$277mn.a.n.a.
Q4 20177$330mn.a.n.a.
Q1 20184$86mn.a.n.a.
Q2 20185$210mn.a.n.a.
Q3 20186$314mn.a.n.a.
Q4 20185$154mn.a.n.a.
Q1 20195$258mn.a.n.a.
Q2 20193$294mn.a.n.a.
Q3 20193$169mn.a.n.a.
Q4 20192$136mn.a.n.a.
Q1 20206$1.2bnn.a.n.a.
Q2 20203$1.2bnn.a.n.a.
Q3 20202$1.3bnn.a.n.a.
Q4 20202$1.4bnn.a.n.a.
Q1 20213$1.5bnn.a.n.a.
Q2 20215$1.4bnn.a.n.a.
Q3 20214$1.3bnn.a.n.a.
Q4 20213$1.1bnn.a.n.a.
Q1 202210$1.8bnn.a.n.a.
Q2 20228$1.6bnn.a.n.a.
Q3 20225$502mn.a.n.a.
Q4 20224$266mn.a.n.a.
Q1 20252$50m20
Q4 20252$9.0m115
Q1 20261$3.4m154
Q2 20261$1.7m414

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

PHG and LLY →PHG and JNJ →PHG and VRTX →Choose a stock to compare with PHG →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own PHG, latest filings →Back to the 13F Explorer →